ReviewEuropean journal of clinical investigation2026
Why Circulating Interleukin-6 Is Not Yet a Standalone Clinically Actionable Biomarker in HFrEF: A Context-of-Use Review.
Yongxin Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.